Hepatology

For patients with the chronic progressive liver disease primary biliary cholangitis (PBC), personalised treatment is key to both…

The management of liver cancer has changed dramatically during the 4 decades since I started as an internal medicine speciality fellow…

Portal hypertension is the major determinant of outcomes in patients with cirrhosis, defined as the presence of a hepatic venous pressure…

Zinc salts are one of three approved treatments for the autosomal recessive condition Wilson’s disease (WD). Their use was first described…

Peginterferon α-2b (Peg IFNα-2b), which inhibits viral replication in infected cells, suppresses cell proliferation, induces apoptosis, and…

Methotrexate (MTX), an antimetabolite, has a multifarious mechanism of action that most notably includes folate antagonism, effects on…

Anil Dhawan – Professor of Paediatric Hepatology, King’s College London, UK. I started in paediatric hepatology in 1992, when I got a…

PBC is a chronic, progressive, immune-mediated cholestatic liver disease that involves gradual intrahepatic bile duct destruction…